Abstract
Plant sterols have an extended history of use as cholesterol-lowering agents. Until the 1970s, the principal interest in plant sterols lay in effects of sitosterol, but over the past decade interest has reemerged in using plant sterols in functional foods. Hydrogenated plant sterols have been shown efficacious in lowering lipid levels, inhibiting cholesterol absorption and regressing plaque in animals. Hydrogenated versus unhydrogenated plant sterol esters have been demonstrated to possess equal efficacy in low-density lipoprotein cholesterol lowering in humans. Unhydrogenated plants sterol esters show consistency in cholesterol-lowering across dosage levels in humans. Unhydrogenated, unesterifed plant sterols yield similar low-density lipoprotein cholesterol lowering efficacy as achieved with hydrogenated sitostanol esters. Solubility and miscibility are likely more important determinants in cholesterol-lowering potential of plant sterols than their specific composition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Pollack OJ, Kritchevsky D: Monographs on Atherosclerosis. New York: Karger; 1981.
Ling WH, Jones PJH: Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 1995 57:195–206.
Jones PJH, MacDougall DE, Ntanios F, Vanstone CA: Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 1997, 75:217–227.
Heinemann T, Axtmann G, von Bergmann K: Comparison of intestinal absorption of cholesterol with different plant sterols in man. Euro J Clin Invest 1993, 23:827–831.
Becker M, Staab D, von Bergmann K: Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr 1993, 122:292–296.
Ntanios FY, Jones PJH: Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits. Atherosclerosis 1999, 143:341–351.
Ntanios FY, Jones PJH: Effects of variable dietary sitostanol concentrations on plasma lipid profile and phytosterol metabolism in hamsters. Bioch Biophys Acta 1998, 1390:237–244.
Miettinen TA, Puska P, Gylling H, et al.: Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. New Engl J Med 1995, 333:1308–1312.
Hallikainen MA, Uusitupa MIJ: Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 1999, 69:403–410.
Weststrate JA, Meijer GW: Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998, 52:334–343.
Hendriks HFJ, Westrate JA, van Vliet T, Meijer GW: Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1999, 83:319–327.
Jones PJH, Howell T, MacDougall DE, et al.: Short-term administration of tall oil phytosterols improves plasma lipid profiles in subjects with different cholesterol levels. Metabolism 1998, 47:751–756.
Jones PJH, Ntanios FY, Raeini-Sarchaz M, Vanstone C: Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr 1999, 69:1144–1150.
Heinemann T, Leis O, von Bergmann K: Effect of low-dose/sitostanol on serum cholesterol in patients with hypercholesterolemia. Atherosclerosis 1986, 61:219–223.
Vanhanen HT, Kajander J, Lehtovirta H, Miettinen TA: Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolemic subjects. Clin Sci 1994, 87:61–67.
Vanhanen HT, Blomqvist S, Ehnholm C, et al.: Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 1993, 34:1535–1544
Gylling H, Miettinen TA: Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 1994, 37:773–780.
Ntanios FY, Jones PJH, Frohlich JJ: Dietary sitostanol reduces plaque formation but not lecithin cholesterol acyl transferease activity in rabbits. Atherosclerosis 1998, 138:101–110.
Denke MA: Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr 1995, 61:392–396
Pelletier X, Belbraouet S, Mirabel D, et al.: A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann Nutr Metab 1995, 39:291–295.
Di Buono N, Hannah JS, Katzel LI, Jones PJH: Weight loss due to energy restriction suppresses cholesterol biosynthesis in overweight, mildly hypercholesterolemic men. J Nutr 1999, in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, P.J.H. Cholesterol-lowering action of plant sterols. Curr Atheroscler Rep 1, 230–235 (1999). https://doi.org/10.1007/s11883-999-0037-3
Issue Date:
DOI: https://doi.org/10.1007/s11883-999-0037-3